Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer

By Anqi Shi, Xi-Yang Tang, Y. Xiong, Kaifeng Zheng, Yu-Jian Liu, Xianpeng Shi, Yao Lv, Tao Jiang, N. Ma, Jinbo Zhao. 2022

Subfields: Cancer Research, Immunology

Citations in the corpus

• Impact of T Cell Exhaustion and Stroma Senescence on Tumor Cell Biology and Clinical Outcome of Head and Neck Squamous Cell Carcinomas (2024, unknown): “LAG-3, a key checkpoint receptor alongside PD-1 and CTLA-4, promotes tumor growth by inhibiting the immune response at high expression levels [15].”